Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII

A Null Mutation in Human <i>APOC3</i> Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

Toni I. Pollin, Coleen Damcott, Haiqing Shen et al. · Science · 2008 · 675 citations · Full text

Hypertriglyceridemia as a Result of Human apo <i>CII</i> Gene Expression in Transgenic Mice

Yasushi Ito, Neal Azrolan, Anita M. O'Connell et al. · Science · 1990 · 541 citations

Genetics, Genetic Epidemiology, Pathology +22

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.

Katriina Aalto‐Setälä, Edward A. Fisher, X Chen et al. · Journal of Clinical Investigation · 1992 · 455 citations · Full text

Hyperlipidemia, Low Density, Oxidative Stress +19

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Henry N. Ginsberg, Ngoc‐Anh Le, Ira J. Goldberg et al. · Journal of Clinical Investigation · 1986 · 419 citations · Full text

Lipoprotein Lipase, Metabolic Syndrome, Apolipoproteins Ciii +15

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

C S Wang, Walter J. McConathy, H. U. Kloer et al. · Journal of Clinical Investigation · 1985 · 415 citations · Full text

Apolipoprotein Levels, Hyperlipidemia, Oxidative Stress +18